What is LOPJLB’s current signal on GENB?

LOPJLB’s latest quantitative signal on Generate Biomedicines, Inc. (GENB) is SELL. Signals are updated daily.

What market regime is GENB in?

LOPJLB classifies each ticker into Bull, Recovery, Ranging, Bear, or Crisis regimes using a Hidden Markov Model.

What does Generate Biomedicines, Inc. (GENB) do?

Generate Biomedicines, Inc. is a U.S.-based company pioneering generative biology, leveraging machine learning for the discovery and advancement of novel protein therapeutics. Their core approach involves developing drugs using protein-based modalities. The company's pipeline includes several key candidates: GB-0895, an investigational long-acting anti-TSLP monoclonal antibody designed for bi-a…

Where is Generate Biomedicines, Inc. based / listed?

Generate Biomedicines, Inc. is based in US, listed on NASDAQ.

Generate Biomedicines, Inc. (GENB)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$14.34+2.50%Close

SELL

RANGE

DATA 2026-10-09

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $1.8B
Beta: -0.14
P/E (TTM): -13.02

Short % float: 13.47%
Days to cover: 5.8
SI change: +3.3%

1W: +4.75%
1M: -6.82%

vs SPY 1W: +3.59%
vs SPY 1M: -9.81%

Industry peers

FMP comparable companies · ranked by market cap

ABCLBUYAbCellera Biologics Inc.$3.9BCRISISQ -6$12.83+4.41%
ABSIBUYAbsci Corporation$1.6BCRISISQ 3$9.22+13.65%
INBXSELLInhibrx Biosciences Inc.$1.4BCRISISQ 33$93.36+2.43%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news